Company Growth (employees)
Sanofi was founded in 2004 and is headquartered in Paris, FR
Key People at Sanofi
Olivier Brandicourt
CEO
Olivier Charmeil
Executive Vice President and General Manager
Jerome Contamine
Executive Vice President & Chief Financial Officer
Karen Linehan
Executive Vice President, Legal Affairs and General Counsel
David Loew
Executive Vice President and General Manager of Sanofi Pasteur
Philippe Luscan
Executive Vice President, Global Industrial Affairs
Alan Main
Executive Vice President, Consumer Healthcare
Muzammil Mansuri
Executive Vice President, Strategy & Business Development
Ameet Nathwani
Executive Vice President, Medical Affairs
Roberto Pucci
Executive Vice President, Human Resources
Elias Zerhouni
President, Global Research & Development
Sanofi Office Locations
Sanofi has offices in Paris, Bridgewater, Macquarie Park, Ontario and in 9 other locations
Paris, FR (HQ)
54, Rue La Boétie
Ho Chi Minh City, VN
10 Ham Nghi, District 1
Séoul, KR
8 Floor Handok Building, 735 Yoksam 1 Dong, Kangnam Ku
Singapore, SG
N°6 Raffles Quay 16 00
Moscow, RU
Sadovnicheskaya Str. 82, Building 2, Entrance 5, 4th Floor
Mexico City, MX
Avenida Universidad 1738, Col. Coyoacán
Sanofi Data and Metrics
Sanofi Financial Metrics
Sanofi's revenue was reported to be €37.1 b in FY, 2015 which is a 10% increase from the previous period.
EUR
Revenue (FY, 2015) | 37.1 b |
Revenue growth (FY, 2014 - FY, 2015), % | 10% |
Gross profit (FY, 2015) | 26.1 b |
Gross profit margin (FY, 2015), % | 71% |
Net income (FY, 2015) | 4.4 b |
Market capitalization (21-Jul-2017) | 102.9 b |
Closing share price (21-Jul-2017) | 82.8 |
Sanofi's current market capitalization is €102.9 b.
- Source: SEC Filings
| EUR | FY, 2013 | FY, 2014 | FY, 2015 |
|---|---|---|---|
Revenue | 33 b | 33.8 b | 37.1 b |
Revenue growth, % | 2% | 10% | |
Cost of goods sold | 10.3 b | 10.2 b | 10.9 b |
Gross profit | 22.6 b | 23.5 b | 26.1 b |
Gross profit Margin, % | 69% | 70% | 71% |
R&D expense | 4.6 b | 4.7 b | 5.1 b |
General and administrative expense | 8 b | 8.4 b | 9.4 b |
Operating expense total | 12.6 b | 13.1 b | 14.5 b |
Depreciation and amortization | 5.1 b | 3.3 b | 4.3 b |
Interest expense | (609 m) | (598 m) | (559 m) |
Interest income | 111 m | 192 m | 178 m |
Income tax expense | 726 m | (1.2 b) | (709 m) |
Net Income | 3.9 b | 4.5 b | 4.4 b |
- Source: SEC Filings
| EUR | FY, 2013 | FY, 2014 | FY, 2015 |
|---|---|---|---|
Cash From Operating Activities | 6.4 b | 6.3 b | 7.2 b |
| EUR | Y, 2015 |
|---|---|
Revenue/Employee | 365.4 k |
Sanofi Market Value History
Sanofi Revenue Breakdown
Sanofi Median Salaries
Source: 9 public H-1B filings from Sanofi
